2020
DOI: 10.1158/1538-7445.sabcs19-p4-06-13
|View full text |Cite
|
Sign up to set email alerts
|

Abstract P4-06-13: Prospective analysis of molecular subtypes in triple negative breast cancer

Abstract: Introduction: Triple negative breast cancer (TNBC) is, in general, associated with unfavorable prognosis. However, TNBC it is a heterogenous disease. Thus, we analyzed the prognosis (RFI, OS) of TNBC in association to the molecular subtypes (according to Lehmann et al. 2011) and the prognostic markers uPA (urokinase-type plasminogen activator) and its inhibitor (uPA/PAI-1) within a prospective cohort of breast cancer patients. Material & Methods: The PiA-study was designed as a multicenter c… Show more

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles